Skip to main content
Premium Trial:

Request an Annual Quote

Helicos BioSciences Closes $40M VC Financing Round

NEW YORK, March 15 (GenomeWeb News) - Helicos BioSciences said today that it has secured $40 million from its current roster of investors to help it develop its DNA sequencing technology.

 

According to Helicos, the financing was provided by Flagship Ventures, Atlas Ventures, Highland Capital, MPM Capital, and Versant Ventures. The latest funding follows an initial investment of $27 million by the same group of investors, made when the company was founded in February 2004.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.